Skip to main content
Figure 1 | BMC Microbiology

Figure 1

From: Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor

Figure 1

Bactericidal activity of PA- 824 on Mycobacterium tuberculosis H37 RV under anaerobic condition. The treatment with 12.5 μg/ml of PA-824 shows a complete reduction in the log CFU/ml after 21 days. P1 and P2: PA-824 at 3 and 12.5 μg/ml; R: Rifampicin at 1 μg/ml; Z: Pyrazinamide at 50 μg/ml.

Back to article page